PubMed · 4015257
Selective decrease of hypothalamic noradrenaline by cysteamine.
Abstract
In dose studies, cysteamine pretreatment in a dose of 200 mg/kg or 300 mg/kg (subcutaneously, s.c.) markedly decreased the hypothalamic noradenaline content, but did not influence the dopamine and serotonin contents. In time studies, pretreatment with cysteamine in a dose of 300 mg/kg (s.c.) led to markedly decreased hypothalamic noradrenaline contents 4 hr, 8 hr and 12 hr after treatment. These results suggest that cysteamine treatment selectively decreases the hypothalamic noradrenaline content in dose- and time-related manners.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
L Vécsei, M Balázs, I Bollók, G Telegdy. 1985. Selective decrease of hypothalamic noradrenaline by cysteamine.. https://pubmed.ncbi.nlm.nih.gov/4015257/
Cite the original work for its findings. Save a collection to share your selection of sources.